Physician profile
Stephen M Cohen
NPI 1275535734
$204,390.09
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141K · 2020: $22K · 2021: $28K · 2022: $14K.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $202,981.47 | 2019-2022 | |
| Amgen INC. | $800.99 | 2019 | |
| Radius Health, INC. | $216.93 | 2019 | |
| Therapeuticsmd, INC. | $78.85 | 2019 | |
| Teleflex LLC | $75.40 | 2019 | |
| Allergan, INC. | $46.75 | 2019 | |
| Novo Nordisk INC | $40.20 | 2019 | |
| Vertical Pharmaceuticals, LLC | $34.84 | 2019 | |
| Pfizer INC. | $24.18 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.83 | 2019 | |
| Ferring Pharmaceuticals INC. | $17.02 | 2019 | |
| Mission Pharmacal Company | $12.81 | 2019 | |
| Coopersurgical, INC. | $12.66 | 2019 | |
| Hologic Sales and Service, LLC | $12.15 | 2019 | |
| Lupin INC. | $12.01 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.